- Home
- GMGI vs SPRO Comparison
GMGI vs SPRO Comparison
Compare GMGI & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- SPRO
- Stock Information
- Founded
- GMGI 2008
- SPRO 2013
- Country
- GMGI United States
- SPRO United States
- Employees
- GMGI N/A
- SPRO N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- SPRO Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- SPRO Health Care
- Exchange
- GMGI Nasdaq
- SPRO Nasdaq
- Market Cap
- GMGI 145.9M
- SPRO 128.9M
- IPO Year
- GMGI N/A
- SPRO 2017
- Fundamental
- Price
- GMGI $1.00
- SPRO $2.33
- Analyst Decision
- GMGI Strong Buy
- SPRO Buy
- Analyst Count
- GMGI 1
- SPRO 4
- Target Price
- GMGI $4.00
- SPRO $5.00
- AVG Volume (30 Days)
- GMGI 205.0K
- SPRO 1.2M
- Earning Date
- GMGI 11-06-2025
- SPRO 11-13-2025
- Dividend Yield
- GMGI N/A
- SPRO N/A
- EPS Growth
- GMGI N/A
- SPRO N/A
- EPS
- GMGI N/A
- SPRO N/A
- Revenue
- GMGI $172,818,124.00
- SPRO $48,576,000.00
- Revenue This Year
- GMGI $25.28
- SPRO N/A
- Revenue Next Year
- GMGI $14.90
- SPRO N/A
- P/E Ratio
- GMGI N/A
- SPRO N/A
- Revenue Growth
- GMGI 54.66
- SPRO N/A
- 52 Week Low
- GMGI $0.91
- SPRO $0.51
- 52 Week High
- GMGI $3.06
- SPRO $3.22
- Technical
- Relative Strength Index (RSI)
- GMGI 44.75
- SPRO 56.08
- Support Level
- GMGI $0.98
- SPRO $2.16
- Resistance Level
- GMGI $1.16
- SPRO $2.42
- Average True Range (ATR)
- GMGI 0.06
- SPRO 0.12
- MACD
- GMGI 0.01
- SPRO -0.00
- Stochastic Oscillator
- GMGI 30.04
- SPRO 46.85
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About SPRO Spero Therapeutics Inc.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.